Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Huh Hoyoung. Director active across 2 companies, notably Akari Therapeutics Plc. Aggregated, 13 reports have been published. Breakdown: 7 buys · 0 sell. Total volume traded: €1k. History available since 1 November 2022. The latest transaction was disclosed on 6 March 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.